United States — Revenue
Guardant Health United States — Revenue increased by 8.0% to $284.63M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 47.0%, from $193.61M to $284.63M. Over 4 years (FY 2021 to FY 2025), United States — Revenue shows an upward trend with a 27.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market penetration, higher clinical adoption of diagnostic tests, or expansion of the domestic customer base. A decrease may signal increased competition, pricing pressure, or challenges in reimbursement coverage within the U.S. healthcare system.
Detailed definition
This metric represents the total gross sales generated from products and services provided to customers located within t...
Peer comparison
Comparable to domestic revenue segments reported by other diagnostic and life sciences companies, often evaluated against total addressable market size and regional market share.
gh_segment_united_states_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $87.87M | $90.42M | $101.97M | $90.87M | $100.84M | $111.10M | $117.82M | $118.91M | $129.26M | $135.74M | $142.62M | $157.35M | $168.12M | $180.11M | $191.59M | $193.61M | $216.68M | $249.44M | $263.55M | $284.63M |
| QoQ Change | — | +2.9% | +12.8% | -10.9% | +11.0% | +10.2% | +6.0% | +0.9% | +8.7% | +5.0% | +5.1% | +10.3% | +6.8% | +7.1% | +6.4% | +1.1% | +11.9% | +15.1% | +5.7% | +8.0% |
| YoY Change | — | — | — | — | +14.8% | +22.9% | +15.5% | +30.9% | +28.2% | +22.2% | +21.1% | +32.3% | +30.1% | +32.7% | +34.3% | +23.0% | +28.9% | +38.5% | +37.6% | +47.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Guardant Health's united states — revenue?
- Guardant Health (GH) reported united states — revenue of $284.63M in Q1 2026.
- How has Guardant Health's united states — revenue changed year-over-year?
- Guardant Health's united states — revenue increased by 47.0% year-over-year, from $193.61M to $284.63M.
- What is the long-term trend for Guardant Health's united states — revenue?
- Over 4 years (2021 to 2025), Guardant Health's united states — revenue has grown at a 27.2% compound annual growth rate (CAGR), from $352.56M to $923.28M.
- What does united states — revenue mean?
- The total amount of money earned from sales within the United States market.